Asset Dedication’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.6K Hold
593
– – ﹤0.01% 616
2026
Q2
$22.6K Hold
593
– – ﹤0.01% 636
2026
Q1
$20.4K Hold
593
– – ﹤0.01% 639
2025
Q4
$19.5K Hold
593
– – ﹤0.01% 669
2025
Q3
$16.9K Hold
593
– – ﹤0.01% 716
2025
Q2
$15.2K Hold
593
– – ﹤0.01% 749
2025
Q1
$16.3K Hold
593
– – ﹤0.01% 685
2024
Q4
$16K Hold
593
– – ﹤0.01% 695
2024
Q3
$17.1K Hold
593
– – ﹤0.01% 717
2024
Q2
$16.2K Hold
593
– – ﹤0.01% 725
2024
Q1
$17K Hold
593
– – ﹤0.01% 612
2023
Q4
$16K Hold
593
– – ﹤0.01% 614
2023
Q3
$15K Hold
593
– – ﹤0.01% 614
2023
Q2
$16K Hold
593
– – ﹤0.01% 599
2023
Q1
$15K Hold
593
– – ﹤0.01% 600
2022
Q4
$16K Hold
593
– – ﹤0.01% 585
2022
Q3
$14K Hold
593
– – ﹤0.01% 572
2022
Q2
$16K Hold
593
– – ﹤0.01% 309
2022
Q1
$16K Hold
593
– – ﹤0.01% 592
2021
Q4
$16K Hold
593
– – ﹤0.01% 582
2021
Q3
$15K Buy
593
+193
+48% +$5.07K ﹤0.01% 619
2021
Q2
$10K Hold
400
– – ﹤0.01% 619
2021
Q1
$10K Hold
400
– – ﹤0.01% 503
2020
Q4
$10K Hold
400
– – ﹤0.01% 556
2020
Q3
$10K Hold
400
– – ﹤0.01% 525
2020
Q2
$9K Buy
+400
New +$8.86K ﹤0.01% 468

Other funds holding FTXH

Asset Dedication's FTXH Position: Q3 2026 in Review

Asset Dedication held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q3 2026 at 593 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Asset Dedication first reported a position in FTXH in Q2 2020 and has held it in 26 quarters since. 57 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • Asset Dedication held 593 shares of First Trust Nasdaq Pharmaceuticals ETF worth $24.6K as of Q3 2026.
  • Asset Dedication left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #616 holding.
  • Asset Dedication first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and has held it in 26 quarters since.
  • 57 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.